IART - Integra Lifesciences Holdings Corp
IEX Last Trade
20.34
-0.370 -1.819%
Share volume: 688,153
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Surgical and Medical Instrument Manufacturing :
-0.56%
PREVIOUS CLOSE
CHG
CHG%
$20.71
-0.37
-1.79%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-10-26 | 2023-02-22 | 2023-04-26 | 2023-07-27 | 2023-10-25 | 2024-02-28 | 2024-05-06 | 2024-07-29 | |
| Assets | |||||||||
| Total Assets | 3.807 B | 3.890 B | 3.742 B | 3.778 B | 3.739 B | 3.782 B | 4.078 B | 4.074 B | |
| Current Assets | 1.196 B | 1.161 B | 1.029 B | 1.051 B | 1.027 B | 1.058 B | 1.416 B | 1.112 B | |
| Inventories | 311.060 M | 324.583 M | 351.275 M | 354.293 M | 366.251 M | 389.608 M | 403.422 M | 421.775 M | |
| Other Current Assets | 123.357 M | 116.789 M | 116.845 M | 129.112 M | 130.976 M | 100.005 M | 108.036 M | 122.429 M | |
| Short Term Investments | 123.357 M | 116.789 M | 116.845 M | 129.112 M | 130.976 M | 100.005 M | 108.036 M | 122.429 M | |
| Total Receivables | 248.268 M | 263.465 M | 253.995 M | 258.663 M | 256.270 M | 259.327 M | 241.092 M | 271.155 M | |
| Current Cash | 511.937 M | 456.661 M | 307.367 M | 309.192 M | 273.732 M | 309.096 M | 663.100 M | 296.927 M | |
| Total Non-current Assets | 2.611 B | 2.728 B | 2.713 B | 2.726 B | 2.712 B | 2.724 B | 2.663 B | 2.962 B | |
| Property Plant Equipment | 300.729 M | 311.302 M | 315.175 M | 317.571 M | 318.718 M | 340.199 M | 345.356 M | 373.570 M | |
| Other Assets | 77.898 M | 57.190 M | 56.183 M | 67.200 M | 77.908 M | 58.194 M | 68.365 M | 70.822 M | |
| Intangible Assets | 1.054 B | 1.127 B | 1.109 B | 1.094 B | 1.067 B | 1.068 B | 1.023 B | 1.220 B | |
| Goodwill | 977.860 M | 1.039 B | 1.042 B | 1.043 B | 1.036 B | 1.055 B | 1.040 B | 1.105 B | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 3.807 B | 3.890 B | 3.742 B | 3.778 B | 3.739 B | 3.782 B | 4.078 B | 4.074 B | |
| Total liabilities | 2.083 B | 2.085 B | 2.067 B | 2.094 B | 2.160 B | 2.194 B | 2.480 B | 2.540 B | |
| Total current liabilities | 304.452 M | 320.906 M | 282.293 M | 377.496 M | 355.712 M | 306.980 M | 302.394 M | 328.316 M | |
| Accounts Payable | 80.732 M | 102.100 M | 112.785 M | 99.766 M | 93.550 M | 92.326 M | 94.397 M | 107.492 M | |
| Other liabilities | 63.729 M | 138.501 M | 126.853 M | 153.340 M | 142.352 M | 199.940 M | 139.745 M | 154.820 M | |
| Current long term debt | 56.250 M | 38.125 M | 0.000 | 95.644 M | 85.387 M | 14.531 M | 19.375 M | 24.219 M | |
| Long term debt | 1.487 B | 1.405 B | 1.440 B | 1.333 B | 1.420 B | 1.485 B | 1.837 B | 1.801 B | |
| Other liabilities | 63.729 M | 138.501 M | 126.853 M | 153.340 M | 142.352 M | 199.940 M | 139.745 M | 154.820 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 1.724 B | 1.804 B | 1.675 B | 1.683 B | 1.579 B | 1.588 B | 1.598 B | 1.534 B | |
| Common stock | 83.042 M | 82.146 M | 81.871 M | 80.966 M | 79.690 M | 77.829 M | 77.735 M | 77.409 M | |
| Retained earnings | 826.172 M | 879.118 M | 903.344 M | 907.528 M | 927.025 M | 946.859 M | 943.578 M | 931.176 M |